Adage Capital Partners Gp, L.L.C. Takeda Pharmaceutical CO LTD Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $4.08 Million - $4.32 Million	-250,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $4.14 Million - $4.66 Million	250,000 New	250,000 $4.21 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $35.8 Million - $44.3 Million	-2,160,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $36.1 Million - $46.5 Million	2,160,000 New	2,160,000 $44 Million

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.